These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17961826)

  • 21. Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis.
    Rauthu SR; Shiao TC; André S; Miller MC; Madej É; Mayo KH; Gabius HJ; Roy R
    Chembiochem; 2015 Jan; 16(1):126-39. PubMed ID: 25407851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Star-pseudopolyrotaxane organized in nanoplatelets for poly(ε-caprolactone)-based nanofibrous scaffolds with enhanced surface reactivity.
    Oster M; Hébraud A; Gallet S; Lapp A; Pollet E; Avérous L; Schlatter G
    Macromol Rapid Commun; 2015 Feb; 36(3):292-7. PubMed ID: 25424726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclodextrin-based multivalent glycodisplays: covalent and supramolecular conjugates to assess carbohydrate-protein interactions.
    Martínez Á; Ortiz Mellet C; García Fernández JM
    Chem Soc Rev; 2013 Jun; 42(11):4746-73. PubMed ID: 23340678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supramolecular design for multivalent interaction: maltose mobility along polyrotaxane enhanced binding with concanavalin A.
    Ooya T; Eguchi M; Yui N
    J Am Chem Soc; 2003 Oct; 125(43):13016-7. PubMed ID: 14570461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
    Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
    Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.
    Cedeno-Laurent F; Barthel SR; Opperman MJ; Lee DM; Clark RA; Dimitroff CJ
    J Immunol; 2010 Oct; 185(8):4659-72. PubMed ID: 20844192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding affinity properties of dendritic glycosides based on a beta-cyclodextrin core toward guest molecules and concanavalin A.
    Ortega-Caballero F; Giménez-Martínez JJ; García-Fuentes L; Ortiz-Salmerón E; Santoyo-González F; Vargas-Berenguel A
    J Org Chem; 2001 Nov; 66(23):7786-95. PubMed ID: 11701037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monovalent interactions of galectin-1.
    Salomonsson E; Larumbe A; Tejler J; Tullberg E; Rydberg H; Sundin A; Khabut A; Frejd T; Lobsanov YD; Rini JM; Nilsson UJ; Leffler H
    Biochemistry; 2010 Nov; 49(44):9518-32. PubMed ID: 20873803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain.
    Miller MC; Klyosov A; Mayo KH
    Glycobiology; 2009 Sep; 19(9):1034-45. PubMed ID: 19541770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailoring the supramolecular structure of aminated polyrotaxanes toward enhanced cellular internalization.
    Yokoyama N; Seo JH; Tamura A; Sasaki Y; Yui N
    Macromol Biosci; 2014 Mar; 14(3):359-68. PubMed ID: 24634263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface.
    Miller MC; Nesmelova IV; Platt D; Klyosov A; Mayo KH
    Biochem J; 2009 Jun; 421(2):211-21. PubMed ID: 19432560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
    Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
    Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimeric lactoside "click clusters" as tools to investigate the effect of linker length in specific interactions with peanut lectin, galectin-1, and -3.
    Gouin SG; García Fernández JM; Vanquelef E; Dupradeau FY; Salomonsson E; Leffler H; Ortega-Muñoz M; Nilsson UJ; Kovensky J
    Chembiochem; 2010 Jul; 11(10):1430-42. PubMed ID: 20549756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways.
    Bi S; Earl LA; Jacobs L; Baum LG
    J Biol Chem; 2008 May; 283(18):12248-58. PubMed ID: 18258591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supramolecular and biomimetic polypseudorotaxane/glycopolymer biohybrids: synthesis, glucose-surfaced nanoparticles, and recognition with lectin.
    Dai XH; Dong CM; Yan D
    J Phys Chem B; 2008 Mar; 112(12):3644-52. PubMed ID: 18318528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linking the structure and thermal stability of beta-galactoside-binding protein galectin-1 to ligand binding and dimerization equilibria.
    Di Lella S; Martí MA; Croci DO; Guardia CM; Díaz-Ricci JC; Rabinovich GA; Caramelo JJ; Estrin DA
    Biochemistry; 2010 Sep; 49(35):7652-8. PubMed ID: 20666428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3.
    Henrick K; Bawumia S; Barboni EA; Mehul B; Hughes RC
    Glycobiology; 1998 Jan; 8(1):45-57. PubMed ID: 9451013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR and MD investigations of human galectin-1/oligosaccharide complexes.
    Meynier C; Feracci M; Espeli M; Chaspoul F; Gallice P; Schiff C; Guerlesquin F; Roche P
    Biophys J; 2009 Dec; 97(12):3168-77. PubMed ID: 20006954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Supramolecular Pharmaceutical Sciences: A Novel Concept for Future Pharmaceutical Sciences].
    Higashi T; Motoyama K; Arima H
    Yakugaku Zasshi; 2019; 139(2):175-183. PubMed ID: 30713226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzyme-responsive supramolecular polymers by complexation of bis(p-sulfonatocalixarenes) with suberyl dicholine-based pseudorotaxane.
    Guo DS; Zhang TX; Wang YX; Liu Y
    Chem Commun (Camb); 2013 Aug; 49(60):6779-81. PubMed ID: 23785710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.